v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets [Abstract]    
Cash and cash equivalents $ 327,447 $ 377,099
Cash collateral posted to counterparties 260,563 244,440
Mortgage-backed securities (including pledged of $7,620,616 and $6,893,629, respectively), at fair value 8,399,925 7,512,087
Due from counterparties 2,645 10,445
Derivative assets 6,791 133
Accrued interest receivable 36,686 32,841
Other assets 10,779 7,534
Total assets 9,044,836 8,184,579
Liabilities:    
Repurchase agreements 7,234,723 6,563,120
Due to counterparties 332,676 341,924
Derivative liabilities 3,810 22,814
Cash collateral posted by counterparties 4,798 0
Accrued interest payable 46,861 44,672
Accrued dividends payable 20,707 16,501
Other liabilities 5,346 10,612
 Total liabilities 7,648,921 6,999,643
Preferred Stock, Liquidation Preference, Value 111,500 111,500
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 180,000,000 shares authorized; 102,226,355 and 84,491,800 shares issued and outstanding, respectively 1,022 845
Additional paid-in capital 1,982,781 1,742,471
Accumulated other comprehensive loss (153,099) (172,489)
Accumulated deficit (542,632) (493,734)
 Total shareholders’ equity 1,395,915 1,184,936
Total liabilities and shareholders’ equity $ 9,044,836 $ 8,184,579

Source

10-Q PDF XBRL Zip